Tissue DonorsGraft vs Host DiseaseHematopoietic Stem Cell TransplantationUnrelated DonorsTransplantation, HomologousDonor SelectionHistocompatibility TestingStem CellsHematopoietic Stem Cell MobilizationTransplantation ChimeraStem Cell TransplantationTransplantation ConditioningBone Marrow TransplantationGranulocyte Colony-Stimulating FactorHematologic NeoplasmsHematopoietic Stem CellsGraft SurvivalWhole-Body IrradiationSiblingsHistocompatibilityBlood DonorsLiving DonorsTreatment OutcomeEmbryonic Stem CellsCord Blood Stem Cell TransplantationAdult Stem CellsPluripotent Stem CellsHLA AntigensPeripheral Blood Stem Cell TransplantationStem Cell NicheLeukemiaNeural Stem CellsInduced Pluripotent Stem CellsRecurrenceCells, CulturedAnemia, AplasticCell DifferentiationT-LymphocytesMesenchymal Stem Cell TransplantationMultipotent Stem CellsAntilymphocyte SerumVidarabineMesenchymal Stromal CellsSurvival AnalysisMyeloablative AgonistsStem Cell FactorSpleenDisease-Free SurvivalLymphocytesFetal BloodPrecursor Cell Lymphoblastic Leukemia-LymphomaImmunosuppressive AgentsBusulfanRetrospective StudiesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHLA-DP beta-ChainsCell LineageHematologic DiseasesSurvival RateTransplantation, AutologousTissue and Organ ProcurementGraft RejectionLymphocyte DepletionStem Cell ResearchMyelodysplastic SyndromesPlant StemsTime FactorsAcute DiseaseFetal Stem CellsLeukemia, Myeloid, AcuteTransplantation ImmunologyCell ProliferationHLA-DP AntigensDirected Tissue DonationRemission InductionAntigens, CD34AllograftsBone Marrow CellsHematopoiesisHLA-A AntigensHemibody IrradiationNeoplastic Stem CellsKidney TransplantationLife TablesCyclosporineRegenerationActuarial AnalysisCell SeparationCell Culture TechniquesTransplantsMice, Inbred C57BLHistiocytosis, Non-Langerhans-CellFlow CytometryInfectionOctamer Transcription Factor-3Follow-Up StudiesTacrolimusMethotrexateHLA-B Antigens